bioRxivNeurosciencePreprint
Integration of eQTL and Parkinson’s disease GWAS data implicates 11 disease genes
Demis A. Kia, David ZhangiD, Sebastian GuelfiiD, Claudia ManzoniiD, Leon HubbardiD, Regina Hertfelder ReynoldsiD, Juan Antonio BotíaiD, Mina RyteniD, Raffaele FerrariiD, Patrick Alfryn LewisiD, Nigel M. WilliamsiD, Daniah TrabzuniiD, John HardyiD, Nicholas William WoodiD
Abstract
Substantial genome-wide association study (GWAS) work in Parkinsons disease (PD) has led to an increasing number of loci shown reliably and robustly to be associated with the increased risk of the disease. Prioritising causative genes and pathways from these studies has proven problematic. Here, we present a comprehensive analysis of PD GWAS data with expression and methylation quantitative trait loci (eQTL/mQTL) using Colocalisation analysis (Coloc) and transcriptome-wide association analysis (TWAS) to uncover putative gene expression and splicing mechanisms driving PD GWAS signals. Candidate genes were further characterised by determining cell-type specificity, weighted gene co-expression (WGNCA) and protein-protein interaction (PPI) networks.\n\nGene-level analysis of expression revealed 5 genes (WDR6, CD38, GPNMB, RAB29, TMEM163) that replicated using both Coloc and TWAS analyses in both GTEx and Braineac expression datasets. A further 6 genes (ZRANB3, PCGF3, NEK1, NUPL2, GALC, CTSB) showed evidence of disease-associated splicing effects. Cell-type specificity analysis revealed that gene expression was overall more prevalent in glial cell-types compared to neurons. The WGNCA analysis showed that NUPL2 is a key gene in 3 modules implicated in catabolic processes related with protein ubiquitination (protein ubiquitination (p=7.47e-10) and ubiquitin-dependent protein catabolic process (p = 2.57e-17) in nucleus accumbens, caudate and putamen, while TMEM163 and ZRANB3 were both important in modules indicating regulation of signalling (p=1.33e-65] and cell communication (p=7.55e-35) in the frontal cortex and caudate respectively. PPI analysis and simulations using random networks demonstrated that the candidate genes interact significantly more with known Mendelian PD and parkinsonism proteins than would be expected by chance. The proteins core proteins this network were enriched for regulation of the ERBB receptor tyrosine protein kinase signalling pathways.\n\nTogether, these results point to a number of candidate genes and pathways that are driving the associations observed in PD GWAS studies.
- organism: human
- assay: GWAS summary statistics
- assay: DNA methylation
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: database / resource
- approach: statistical model
- approach: benchmark study
- Citations
- 11
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrating dorsolateral prefrontal cortex multi-omics and GWAS summary data enhances gene-mapping of Parkinson's disease
Qiang Liu, Shinya Tasaki, … Jingjing Yang·medRxiv·Oct 5, 2026
- Establishing gene regulatory networks from Parkinson's disease risk loci
Sophie L. Farrow, William S. Schierding, … Justin Martin O'Sullivan·BrainPeer-reviewed·Jan 25, 2022
- A Computational Approach in Identification of Putative Risk Genes in Parkinsons Disease
Bhargav Dave, Prasenjit Majumder, Shamayeeta Sarkar·bioRxiv·Oct 13, 2021
- Prioritizing Parkinson’s Disease genes using population-scale transcriptomic data
Yang Li, Garrett T. Wong, … Towfique Raj·Nature CommunicationsPeer-reviewed·Mar 1, 2019
- Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator
Isabel Alfradique‐Dunham, Jessie Sanford, … Miguel Minaya·bioRxiv·Aug 21, 2026
- Detection of Parkinson’s disease using blood and brain cells transcript profiles
Mohammad Ali Moni, Humayan Kabir Rana, … Julian M.W. Quinn·bioRxiv·May 13, 2019